Moderna/ US60770K1079 /
2024-03-28 8:59:58 PM | Chg. -4.07 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
106.53USD | -3.68% | 90,617 Turnover: 9.78 mill. |
-Bid Size: - | -Ask Size: - | 40.64 bill.USD | - | - |
GlobeNewswire
2:00 PM
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congr...
GlobeNewswire
03-04
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire
02-29
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire
01-12
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
GlobeNewswire
01-09
PRISM MarketView Honors National Biotechnology Month with a Spotlight on Emerging Biotech Innovators
GlobeNewswire
2023-12-21
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference